Lundbeck Seizure Drug Poses Serious Skin Risks, FDA Warns

Law360, New York (December 3, 2013, 3:11 PM EST) -- Drugmaker Lundbeck Inc.'s seizure medication Onfi may cause rare but potentially fatal skin reactions including toxic epidermal necrolysis, a condition characterized by the peeling away of skin cells, the U.S. Food and Drug Administration warned Tuesday.

The agency, which said it has approved label changes to alert consumers about these life-threatening skin reactions, said that the reactions could occur any time during the treatment but that patients could be particularly vulnerable to it during the first two months of their treatment, or when they restart the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.